Skip to main content

Before you Buy: Check the Credit Tab to Make Sure Your Jurisdiction is Accredited!

Back to Search

 This program is not active.
Webinar

International Webinar: Mexico Cannabis Legalization


Average Rating:
   7
Categories:
International Law |  Administrative Law |  Business |  Cross Border Markets & Commerce |  Regulation law |  Webinar with CLE credit
Faculty:
Jason Moscovici |  Juan Luis Serrano Leets |  Juliana Martinez Montaño Martinez Montaño |  Manuel Quintanilla |  Ricardo Ramirez |  Rod Kight
Duration:
1 Hour
Format:
Audio and Video
SKU:
INCBA02242021WEB
License:
Product Setting: Expires 6 month(s) after program date.

Dates


Description

Mexico has been taking steps towards legalization of both Medical and Adult use Cannabis. The panel will look at recent developments and pending policy items from a regulatory, public affairs and business perspectives.

Credits



Handouts

Faculty

Jason Moscovici's Profile

Jason Moscovici Related Seminars and Products

Partner, Lawyer, Biochemist

Robic, LLP


Jason Moscovici is a partner, lawyer and biochemist with ROBIC, LLP, a multidisciplinary intellectual property law firm from Quebec, Canada. His IP practice specializes in regulated industries such as food, alcohol, cannabis, pharmaceuticals, medical devices, cosmetics, natural health products, advertising and consumer products.

Jason’s focus on the valorization and enforcement of intellectual property, as well as the numerous compliance issues that orbit regulated industries, have allowed him to quickly become one of the most trusted legal advisors to the emerging cannabis industry. His perspectives on compliance, intellectual property and the commercial hurdles related specifically to cannabis are routinely solicited by stakeholders in this space.

Jason leads ROBIC`s cannabis group and sits on the life sciences committee of the firm.


Juan Luis Serrano Leets's Profile

Juan Luis Serrano Leets Related Seminars and Products

Partner

Sánchez DeVanny Eseverri, S.C.


Juan Luis leads the Intellectual Property and Data Privacy practice groups at Sanchez Devanny and is the co-head of their Life Sciences Industry Group.  He has broad experience in high level management of complex legal and policy issues in Mexico and Latin America.

Juan Luis is Councilor to the Mexican Health Foundation (FUNSALUD), a member of the board of the Association of Pharmaceutical Industry Physicians and Professionals (AMEIFAC) and of the Commission of Legal Affairs of the National Chamber of the Pharmaceutical Industry (CANIFARMA).

He is also a professor of Sanitary Law in the Escuela Libre de Derecho and the Universidad Panamericana. 

Before joining Sánchez Devanny, Juan Luis was Legal Director of the Mexican Affiliate of a Multinational Pharmaceutical Company, with responsibilities over Mexico and Latin America, and worked in law firms specializing in intellectual property.


Juliana Martinez Montaño Martinez Montaño's Profile

Juliana Martinez Montaño Martinez Montaño Related Seminars and Products


Juliana has 20 years of experience working in Regulatory Affairs in
Mexican and Multinational Pharmaceutical Companies, including Stendhal
Pharma and Sanofi Aventis. She was also in charge of the regulatory
strategy for Mexico for Khiron Life Sciences Corp, focusing on cannabis
products in healthcare.
Juliana currently works as regulatory consultant aiding companies in the
cannabis, pharmaceutical, medical devices, food and cosmetics industries
in proceedings before the Federal Commission for Protection Against
Sanitary Risks.


Manuel Quintanilla's Profile

Manuel Quintanilla Related Seminars and Products

Head of Business Development

SmartCbd


3 Years as Business development Consultant at DriveOp Business Acceleration firm.

Currently Managing the business development department for Smartcbd portafolio


Ricardo Ramirez's Profile

Ricardo Ramirez Related Seminars and Products

Partner Hudde & Rynd. Director

AFAMELA (Mexican Association of Free Access Drug Manufacturers


RICARDO RAMÍREZ-MONTOYA Has a Law Degree from the Ibero-American University, has postgraduate studies in North American Law from Georgetown University, a Master's Degree in Economic History from the Ibero-American University and is a candidate for a Doctor of Business Law from the Complutense University of Madrid. As a consultant in regulation and lobbying, he has participated in the integration and approval of important reforms applicable to the pharmaceutical sector (Compulsory Licenses, Linkage, Biotechnological Medicines, Sanitary Registry of health supplies, Advertising of Medicines, public sector purchases, among others). He has served on the Board of Directors of global companies in the pharmaceutical sector (Sanofi 2009-2013: Product Patrimony Management, Corporate Affairs, Strategic Communications and Public Relations; and Pfizer 2013-2017: Corporate Affairs, Communications, PAG’s and President of the Foundation); currently holds leadership positions in AFAMELA (Executive Director, Board and Advertising Ethics Committee member), Wellness Council México (President of the Government Relations Committee), CANIFARMA (Permanent Guest to the Board of Directors), the Glosbal Self-Care Federation ( Member of the Board of Directors based in Geneva), the Latin American Industry of Responsible Self-Care ILAR (Board Member based in Chicago). The last 15 years he has represented Forbes-100 companies in business organizations such as AMIIF (Technical Vice President of the Public Affairs and Intellectual Property Commissions), AmCham Mexico, the Franco-Mexican Chamber of Industry and Commerce (Vice President of the Social Responsibility Committee), PhRMA (Representative of Mexico in the LARC Regional Committee based in Washington DC), CANIFARMA (President of the Intellectual Property Commission). He was part of the business delegation of CONCAMIN that accompanied the negotiations of the TPP, Pacific Alliance and United States - Mexico and Canada Trade Agreements (USMCA), representing the pharmaceutical sector for the Government Procurement chapters , Intellectual Property and Dispute Resolution Mechanisms. He received the COEBIO Bioethics award in November 2016 and was part of the Qualifying Jury of the National Award for Voluntary and Solidarity Action, delivered by the President of the United Mexican States in December 2016. Since that year he has been a mentor for new entrepreneurs and a jury in the MassChallenge Accelerator (Mexico and Boston) and Startup HUB CDMX from Facebook programs. He is the author of publications on health regulation and legal history, as well as a frequent lecturer in analysis programs on health and business in Mexico and abroad. He is currently the Health Law Committee Chair of the Illustrious and National Collegium of Lawyers of Mexico and Managing Director of Hudde & Rynd, public affairs firm specialized in strategic communications and health regulation.


Rod Kight's Profile

Rod Kight Related Seminars and Products

Attorney | Author | Advocate

Kight Law Office, PC


Rod is a cannabis business law attorney. Based in North Carolina and Mexico, Rod represents legal cannabis businesses throughout the world and is editor and chief writer of the Kight On Cannabis law blog. Rod is the author of “Cannabis Business Law-What You Need to Know”, published by Aspatore Books. He has served on the advisory board for the American Journal of Endocannabinoid Medicine, for which he has also written a legal column. Rod also created the “Source Rule”, which is widely regarded as a primary legal foundation for the contemporary hemp market in cannabinoids and other cannabis materials.

Rod is frequently quoted on cannabis matters by trade publications and major media outlets including the Wall Street Journal, Time, Politico, and Business Insider. Additionally, Rod has been listed in MG Magazine's list of "30 Powerful Litigators", Hemp Connoisseur Magazine’s list of “100 People You Should Know”, and High Time's "2020 Leaders in Cannabis Law." He is part of the legal teams in two high-profile cases against the DEA and the Texas Department of State Health Services regarding hemp extracts, has drafted and presented cannabis legislation to a foreign head of state, is a member of the board of directors of a publicly traded Canadian cannabis and psychedelics company, testified to the FDA about CBD and cannabis compounds, and is a partner in a Mexican import-export company focused on legal cross-border hemp transactions. Rod routinely advises in-house counsel and C-suite level executives on cannabis issues. He has discussed cannabis legal issues in numerous seminars to lawyers, business executives, and public officials and is regularly asked to be a guest speaker on US and inter- national podcasts about cannabis and psychedelics.

Rod is a strong believer in cannabis for personal and medical use after using it successfully during chemotherapy treatments for cancer (he is in remission). He has been an attorney advocate for NORML and has also been a member of the International Cannabis Bar Association, the National Cannabis Industry Association, the Hemp Industries Association, and the Southeast Hemp Association.


Reviews

5
4
3
2
1

Overall:      4

Total Reviews: 7